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The production of dendritic cells (DC) from haemopoietic progenitors maintained in long
term stroma-dependent cultures (LTC) of spleen or bone marrow (BM) occurs independently
of added granulocyte/macrophage colony stimulating factor (GM-CSF). The possibility that
cultures depend on endogenous GM-CSF produced in low levels was tested by attempting to
generate LTC from spleen and BM of GM-CSF-/- mice. Multiple cultures from GM-CSF
-/-
and wild type mice were established and compared for cell production. GM-CSF-/- LTC
developed more slowly, but by 16 weeks produced cells resembling DC in numbers compara-
ble to wild type cultures. LTC maintained distinct populations of small and large cells, the lat-
ter resembling DC. Cells collected from GM-CSF-- z- LTC were capable antigen presenting
cells (APC) for T cell stimulation and morphologically resembled DC. Large cells expressed
the CDllb, CDllc, CD86, 33D1 and Dec-205 markers of DC. Addition of GM-CSF to
GM-CSF-/- LTC increased the proportion of large, mature DC present in culture. Stromal cells
from GM-CSF-/- LTC could support the differentiation of DC from early progenitors main-
tained in LTC without addition of GM-CSE However, GM-CSF is not a critical factor in the
in vitro generation of DC from progenitors. It can, however, substitute for stromal cells in
increasing the survival of mature DC.
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INTRODUCTION
Dendritic cells (DC) are central to immune response
development, being the primary antigen presenting
cells (APC) capable of stimulating na’ve T cells.
Attempts to study DC development and to identify
genes and proteins which regulate cell differentiation
and function have been impeded by the scarcity of
DC in tissues and the difficulties associated with their
isolation.
There is currently evidence for at least three dis-
tinct DC lineages, including Langerhans cells in skin,
myeloid DC and lymphoid DC (Shortman & Caux,
1997). It is believed that GM-CSF is an essential fac-
tor for development of DC of the myeloid lineage.
The importance of GM-CSF has been demonstrated
in many independent studies using different starting
cell populations including CD34
/ BM progenitors,
peripheral blood monocytes and DC precursors iso-
lated by various means from a number of lymphoid
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sites including spleen, lymph node and bone marrow
(BM) (reviewed by Caux & Banchereau, 1996). For
example, GM-CSF, Intedeukin(IL)-4 and TNF-t are
used commonly to induce DC production from blood
monocytes for use in immunotherapy. Similar combi-
nations of GM-CSF, IL-4 and stem cell factor (SCF)
can be used to expand DC out ofBM or cord blood.
Despite the common usage of GM-CSF in DC cul-
ture, mutant mice deficient in production of either
GM-CSF or its receptor still produce nearly normal
numbers of DC (Vremec et al., 1997). Similarly,
GM-CSF transgenic mice or mice receiving an infu-
sion of GM-CSF, do not have increased numbers of
DC in most lymphoid sites except in lymph node and
peritoneal cavity (Maraskovsky et al., 1996; Vremec
et al., 1997). These results are consistent with other
evidence that development of lymphoid DC from
thymic precursors or pro-B cells can occur independ-
ently of GM-CSF (Bjork & Kincade, 1998; Saunders
et al., 1996).
A long term culture (LTC) system for production of
murine DC has been developed which generates a
continuous supply of immature DC from haemopoe-
itic precursors maintained ,within the culture without
the addition of GM-CSF (Ni & O’Neill;
1997,1998,1999; O’Neill et al., 1999a). Continuous
production of cells depends on the presence of a stro-
mal cell layer of endothelial and fibroblastic cells. A
constant population of cells is released into the cul-
ture supernatent and can be readily collected for anal-
ysis. Cells produced in LTC have a cell surface
phenotype resembling DC with high levels ofCD 1 lb,
CDllc, 33D1 and CD80/CD86 (Ni & O’Neill, 1997;
Ni & O’Neill, 2000). Their cell surface phenotype is
more consistent with myeloid DC since the great
majority of cells are CD8- and Dec-205-.
LTC-DC maintain the functional characteristics of
DC, being endocytic (Ni & O’Neill, 1997) and highly
potent APC (O’Neill et al., 1999a). They are migra-
tory and can induce a protective anti-tumour immune
response when pulsed with tumour membranes prior
to adoptive transfer into mice (O’Neill et al., 1999b).
The majority of CD 1 lc
/ cells produced in culture do
not express the CD8t marker (Ni & O’Neill, 2000)
which has been used to identify murine lymphoid DC
in thymus (Saunders et al., 1997), spleen (Leenan et
al., 1998) and lymph node (Salomon et al., 1998).
This result is consistent with LTC producing myeloid
DC. However, development ofDC in LTC depends on
the presence of stromal cells and occurs independ-
ently of added GM-CSF, which is more consistent
with lymphoid DC (Ni & O’Neill; 1997, 1998).
Growth factors which support DC production from
progenitors remain undefined, but DC production
occurs independently of factors known to affect DC
colony formation including GM-CSF, IL-3, IL-4,
IL-6, TNF-ct, SCF, IL-7 and IL-1 (Wilson et al., 2000
a; Ni & O’Neill, 1997).
Since DC of different lineages may be functionally
distinct it is important to determine the lineage char-
acterigtics ofLTC-DC and the soluble factors and sig-
naling events essential to their development. The
hypothesis that LTC-DC production is driven by low
levels of endogenously produced GM-CSF has been
tested by attempting to generate LTC producing DC
from spleen and BM of GM-CSF-/- mice. Cultures
producing DC can be generated independently of
GM-CSF in knockout mice. Furthermore, GM-CSF
can substitute in vitro for other stroma-derived factors
in supporting the survival of cells already committed
to the DC lineage.
RESULTS
Production ofLTC-DC from spleen andBM
occurs independently ofGM-CSF
Spleen and BM from GM-CSF-/- [129 x C57BL/6J]
Flmice and syngeneic wild type (WT) mice were
compared for production of LTC supporting haemo-
poiesis. At least 6 spleen LTC were established from
individual mice of each strain and development of
cells followed over time. Success rate in establish-
ment of LTC was similar for both strains although
stroma development was slower in GM-CSF-/- LTC.
After 10 days, spleen LTC from GM-CSF-/- mice had
less endothelial cell growth and produced fewer
non-adherent cells than LTC fromWT spleen (Fig. 1).GM-CSF-INDEPENDENT DENDRITIC CELL DEVELOPMENT 135
FIGURE Development ofDC in spleen LTC from GM-CSF/- mice. LTC from GM-CSF-/ (A,C) and wild type (WT) (B,D) littermate con-
trol mice are shown at 10 days (A,B) and 28 days (C,D). Differences in extent of stroma development are shown at 10 days. Haemopoietic
cells forming on top of stroma is shown in LTC from GM-CSF--/and wild type (WT) littermate control mice at 4 weeks when DC with typi-
cal morphology are released into the supernatent. Magnification" 200x (A, B, D), 320x (C)
Over the same period, WT spleen LTC supported hae-
mopoiesis of cells earlier than did GM-CSF-/- LTC.
By 4 weeks there was more similarity between cul-
tures. Clear foci were present in both GM-CSF-/- and
WT cultures on well developed stroma containing
both fibroblasts and endothelial cells (Fig. 1). DC136 KEPING NI and HELEN C. O’NEILL
were detectable as non-adherent cells present in the
medium of both GM-CSF-/- and WT LTC after 4
weeks of culture.
Interdigitating DC were microscopically detectable
amongst freshly isolated BM cells of GM-CSF-/-mice
suggesting that development of DC in vivo can occur
independently of GM-CSF (data not shown). Stroma
was well developed by 10 days inBM LTC from both
GM-CSF-/-andWT mice. At this stage, fewer haemo-
poietic cells were present in GM-CSF-/-than WT cul-
tures (Fig. 2), consistent with absence of GM-CSF
which supports early BM haemopoiesis. By 4 weeks,
stroma was well developed in all LTC, with clear evi-
dence ofDC amongst the non-adherent cells (Fig. 2).
LTC derived from spleen and BM of both
GM-CSF
-/- and WT mice were easily maintained for
16 weeks. Cell production was monitored continu-
ously over that time by collection of an aliquot of
non-adherent cells. The presence of two clear subsets
of large and small cells, characteristic ofLTC (Wilson
et al., 2000 b), was assessed by Forward and Side
Scatter analysis on the FACS. By comparison, the
well established LTC-X1 line maintains a constant
high production (87%) o,f large DC amongst the
non-adherent cell population (Fig. 3). The percentage
of large cells produced by GM-CSF-/- spleen LTC
increased steadily over 11 weeks to reach levels of
30-40% of non-adherent cells (Fig. 3). The percent-
age of large cells produced in GM-CSF-/- BM LTC
was much lower, reaching levels of only -10% after
11 weeks. By 14 weeks, GM-CSF-/- spleen LTC con-
tained 35% large cells while WT spleen LTC had
-48% large cells. In line with previous findings on
BM LTC which are slower producers of DC (Ni and
O’Neill, 1997), the large cell population in both
GM-CSF
-/- and WT BM LTC represented only -20%
of cells. A secondary 14-week culture of GM-CSF-/-
BM on LTC-X1 stroma (Ni & O’Neill, 1999) pro-
duced-30% large DC.
Phenotypic identification ofDC produced
in GM-CSF"/" LTC
LTC were monitored over time for production of cells
representing different haemopoietic lineages using
FIGURE 2 Development ofDC inBM LTC from GM-CSF-/- mice.
BM LTC derived from GM-CSF-/- is shown at 10 days and 4 weeks
(A,C). BM LTC from wild type (WT) control mice is shown at 10
days (B). Well developed stroma was observed by day 10 in all cul-
tures but haemopoiesis occurred only in WT cultures (B). Den-
dritic-like cells were present in all cultures ofWT and GM-CSF-/-
mice by 4 weeks (C)GM-CSF-INDEPENDENT DENDRITIC CELL DEVELOPMENT 137
FACS analysis and antibodies specific for markers
expressed by myeloid, dendritic and lymphoid cells.
Multiple cultures were analysed for up to 14 weeks to
estimate the proportion of different cell types present
in the non-adherent cell subset produced during the
early stages ofLTC development. Over the first 3 to 7
weeks, cells produced comprised a mixture of small
cells with low Forward and Side Scatter, subpopula-
tions of which stained positively for CDllb (mye-
loid/DC) and 33D1 (DC) (all data not shown). Clear
subpopulations of small B220+ B cells and Thy-1
/ T
cells were detectable in spleen LTC. By 11 weeks,
these subsets had virtually disappeared. Similar
results were obtained for all cultures but representa-
tive results obtained for just one GM-CSF-/- spleen
LTC, 8GS 1.4, are given. FACS profiles of cell surface
marker on non-adherent cells collected from 8GS 1.4
at 11 to 14 weeks after initiation of culture are shown
in Fig. 4 along with profiles of the established
LTC-X1 cell line. Cells with high Side Scatter in
LTC-X1 stain strongly for CDllb, 33D1, CDllc and
F4/80 with subsets of cells staining for MHCII and
Dec-205 (Fig. 4 & Wilson et al., 2000 b). There are
no cells present whic,h express Thy-1 and B220 which
mark lymphoid cells. No Gr-1
/ cells are produced by
LTC-X1 (data not shown).
Cultures of 8GS1.4 showed clear development of
very large cells with high FSC/SSC. Cells with high
SSC stained positively for CD 1 lb, CD11c and F4/80
in numbers comparable with LTC-X1 (Fig. 4). A high
proportion (45%) of cells expressed Dec-205, a DC
marker, and MHC Class II (71%), which is expressed
by DC at different stages during development. These
two markers are expressed by a smaller subset of
LTC-X1. The presence of a small population of DC
expressing high levels ofMHCII in LTC-X1 has been
associated with a predominance of immature DC with
low expression of MHCII (Ni & O’Neill, 2000). DC
produced in GM-CSF-/- LTC at 14 weeks differ from
LTC-X1 derived DC in terms of MHCII expression.
High expression of cell surface MHCII on DC has
been associated with very early DC precursors and
with mature DC capable of T cell stimulation (Pierre
et al., 1997). By 14 weeks, cultures contained a large
subpopulation of Thy-1
/ cells (-50%) with high SSC
distinguishable from a 4% population of small
Thy-I/T cells. The significance of Thy- 1 expression
is not yet clear, but aberrant expression could be
related to culture conditions.
Although cells produced in GM-CSF-/- LTC do not
uniformly express DC markers until-11 weeks of
culture, cells present in the early stages of culture are
very effective APC in an MLR. In Fig. 5, non-adher-
ent cells collected from the GM-CSF-/- spleen LTC
8FZ8.1 after 8 weeks, can stimulate proliferation of
syngeneic (C57BL/6J) and semi-allogeneic
(B10.A(2R)) spleen responders with up to 25-fold
increase in proliferation above background. In con-
trast, LTC-X3 cells are more effective stimulators of
lymphocytes of B10.A(2R) and allogeneic BALB/c
.and C57BL/6J responders. These effects can be
achieved with very small numbers of APC, e.g.
<100 APC per well. Functional immunostimulatory
DC are produced in GM-CSF-/- spleen LTC as early
as 8 weeks before clear populations of DC are identi-
fiable by marker expression.
Across all LTC there was consistent, slow out-
growth of DC in spleen and BM LTC of
GM-CSF-/-mice as other cell subsets disappeared
from culture. The outgrowth of DC in early cultures
was, however, slower than in LTC derived from WT
or other non-mutant strains of mice (Ni & O’Neill;
1997,1998). Cell production was maintained even
after 16 weeks for 8GS1.4, with 41% of cells repre-
senting large DC with high FSC. The proportion of
CDllc
/ cells had increased to 95% of large cells
cells. Only 21% of the CDllc
/ cells coexpressed
MHCII, which is more consistent with marker distri-
bution on LTC-X1 cells and the predominance of
immature DC in LTC (Fig. 6). Amongst the small cell
population, 88% of cells were CDllc
/ with 49% of
cells expressing low levels of MHCII.
Effect of addition ofGM-CSF to GM-CSF"/" LTC
GM-CSF is not a critical factor in the development of
DC from progenitors maintained in LTC. To test the
alternative hypothesis that GM-CSF may act at a later
stage during development to support replication,
development or maintenance of DC precursors,138 KEPING NI and HELEN C. OEILL
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FIGURE 3 Size distribution of non-adherent cells produced in spleen (SPL) andBM LTC derived from GM-CSF-/-(KO) and wild type con-
trol (WT) mice. A.) Data from representative cultures indicate the percentage of large cells present in individual cultures. Gates were set
according to the distribution of large cells present in the well established LTC-X1 cell line. Development ofKOBM on LTC-X1 stroma (sec-
ondary LTC) was also compared. B.) The production of large cells by spleen andBM LTC of GM-CSF- mice was followed over 11 weeks
(mean+/-SE of eleven cultures)GM-CSF-INDEPENDENT DENDRITIC CELL DEVELOPMENT 139
I1-14 WKS
FIGURE 4 Cell surface antigen expression on cells produced in LTC 8GS 1.4 derived from GM-CSF-/- mice at 11 to 14 weeks after establish-
ment of cultures. Non-adherent cells were collected from LTC and stained using specific fluorochrome-labelled antibodies. The production
of large DC is indicated by the population of cells with high FSC and SSC (left column). Marker expression is indicated in plots of SSC ver-
sus Fluorescence. Percentage of cells staining with specific fluorescent antibody was estimated using isotype control antibodies to set gates
for positive staining. Staining of DC produced by the established LTC-X1 line is shown in the bottom row for comparison. Gates are
included in some plots to indicate subsets which stain positively
GM-CSF was added into the established 8GS4.1
GM-CSF
-/- spleen-derived LTC at 16 weeks. The
effectof GM-CSF on production of DC was moni-
tored by FACS analysis over 12 days. GM-CSF was
maintained at 300 U/ml for 12 days with a medium
change every 3 days and the size and marker expres-
sion of cells produced was monitored by removal of
an aliquot of non-adherent cells.
Initially, addition of GM-CSF resulted in an
increase in the number of large non-adherent cells
present in culture. By 3 days there was a notable
increase in the % large cells over the starting popula-
tion (Day 0). The culture composition changed from
41% to 76% large cells and a higher proportion of
large cells was maintained over the 12 days of the
experiment (Fig. 6). GM-CSF could be acting to
increase the number of small or precursor cells which
develop into large cells or enhance the number of
large cells. There was a transient reduction in the
level of expression of CDllc on both the large and
small cells at 3 days coincident with this change in
cell production (Fig. 6). However, by 12 days, the
proportion of large cells which are CDllc
/ increased
to 73%, with 65% of small cells also CDllc/. Small
subpopulations of CDllc/MHCII+cells were also
detectable. Similar changes were also observed in 3
other LTC after addition of GM-CSF (all data not
shown). By 12 days after GM-CSF addition, distribu-
tion of CD1 lc+ or MHCII+ cells amongst the small
and large cell subsets resembled that of the starting
cell population. The DC phenotype of cells was also
confirmed by the high expression of CD86 on 96% of
the large cells and on -90% of the small cells. This
was measured at 6 and 12 days after exposure to
GM-CSF (Fig. 6). CD86 is consistently expressed by
>90% of large LTC-X1 cells and by -90% of small
cells and has been consistently expressed on LTC-X1
cells over-7 years (Fig. 6). In similar experiments
using LTC from norml mice, GM-CSF has been
shown to expand the number of large DC produced
(Ni & ONeill, data not shown). However, continuous
addition ofGM-CSF to cultures reduces the small cell
population over time and DC production in LTC
ceases.
GM-CSF acts as a maintenance factor forDC
The effects of GM-CSF on DC versus their progeni-
tors was determined by assessing the type of cells col-
lected from LTC which survive and proliferate to
form colonies in semi-solid agar colony assays.
Assays involved non-adherent cells collected from
GM-CSF-/- spleen LTC. These assays have been per-
formed previously to quantitate the production ofDC
colonies from non-adherent cells generated in LTC
(Wilson et al., 2000 a). GM-CSF supported the for-140 KEPING NI and HELEN C. O’NEILL
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FIGURE 5 Induction ofMLR by DC produced after 8 weeks by spleen LTC derived from GM-CSF-/- mice (8FZ8.1). Responders were 105
spleen mononuclear cells from different strains of mice: BALB/c(]), C57BL/6J((C)), and B10.A(2R)(A). These were cultured for three days
in an MLR with varying numbers of non-adherent APC derived from 8FZ8.1 or from control B 10.A(2R)-derived LTC X3. Proliferation was
measured by incorporation of 3H-T in the final 6 hours of culture. Controls included non-adherent cells from 8FZ8.1 alone (@). Responders
in the absence of 8FZ8.1 gave backgrounds of <800 cpm
mation of a small number of 30 colonies of cells
with short membrane extensions (Type II; Table I).
Colonies representative of other haemopoietic cell
types or undifferentiated cells, were not detected in
these experiments. This confirms the production of
only DC/DC progenitors in LTC. A smaller number
of similar colonies also formed when cultures were
supplemented with stromal cells (104) collected from
GM-CSF-/- spleen LTC (Table 1). Not all progenitors
produced in LTC are GM-CSF-dependent but a small,
significant number, perhaps representing a different
lineage, do respond to GM-CSE Conditioned medium
alone from LTC derived from either GM-CSF-/- or
WT spleen did not provide equivalent growth support
in these experiments.
TABLE Conditions which support colony formation amongst non-adherent cells produced in LTC generated from spleen of GM-CSF-/-
mice,
Support medium 4 Frequency ofCFCb
DC colonies (Type I) DC colonies (Type II) Single DCd
Nil 0,0,0 1,3,4, 0,1,2
CSN-wild type LTC 0, 0, 2 4, 5, 5 4, 6, 6
CSN-mutant LTC 0, 0, 0 3, 5, 5 1, 1, 2
GM-CSF 0, 0, 28, 30, 35 342, 399, 494
KO Stroma 2, 4, 4 12, 20, 21 459, 511,570
a. CFC colony forming cell number per 105 cells plated in agar. Colonies are scored as clusters of 5 or more DC present after 14 days.
The non-adherent cells population was collected from 14 week old spleen LTC derived from GM-CSF-/- mice. Data represent CFC in three
replicates.
b. Assays were supplemented with either 50% CSN from LTC-X1 (wild type) or LTC generated from GM-CSF-/- mice (8FZ8.1), GM-CSF
or 10 stromal cells derived from the GM- CSF-/- LTC (8FZ8.1). at 300U/ml 4
c. DC colonies were identified morphologically. Type colonies contain DC with obvious short or long membrane extensions. Type II col-
onies contain only large rounded cells with short membrane extensions. No other colony types were detected.
d. Single DC or clusters of less than 5 cells with veils or membrane extensions.GM-CSF-INDEPENDENT DENDRITIC CELL DEVELOPMENT 141
Colony assays using cells from GM-CSF-/- spleen
LTC which were supplemented with stromal cells or
GM-CSF alone, contained a large number (-4-500)
of individual, viable, mature DC characterised by
long membrane extensions (Table I). Both GM-CSF
and stromal cells can individually support the survival
but not the replication of fully developed DC in col-
ony assays. Cells did not survive in assays supple-
mented with conditioned medium from either
GM-CSF-/- or WT spleen LTC in the absence of
stroma or GM-CSE All data confirm the essential
role of stromal cells in the production of DC in LTC
consistent with previous studies which failed to detect
production of GM-CSF in LTC (Ni & O’Neill, 1997).
However, GM-CSF can act as a very effective alterna-
tive maintenance factor for mature DC survival. It
also supports proliferation/differentiation of a small
number ofDC colonies from progenitors.
DISCUSSION
Previously it was shown that cells resembling DC
both functionally and phenotypically could be pro-
duced in LTC without the addition of an exogenous
source of GM-CSF (Ni & O’Neill; 1997,1998,1999).
This result contradicted many other reports on the
importance of GM-CSF in production of DC in vitro
from precursors isolated from blood, BM and periph-
eral lymphoid sites. A soluble biologically active fac-
tor resembling GM-CSF could not be detected in
conditioned medium collected from LTC (Ni &
O’Neill, 1997). However, it was not possible to rule
out the presence of endogenously produced GM-CSF
secreted in very low levels or produced and presented
to cells via a cell bound receptor such as heparan sul-
phate (Roberts et al., 1988).
Data presented here relate to the importance of
GM-CSF in DC development. While GM-CSF is not
a critical factor in DC development in LTC, it can act
as a maintenance factor to increase the survival ofDC
in vitro. Even as a maintenance factor it is not critical
and stromal cells from GM-CSF-/- mice can act as an
effective substitute support matrix and there may be
other stroma produced factors which can maintain DC
survival. Recent investigations have also confirmed
the absence of GM-CSF gene transcription amongst
the total cell population produced in LTC from wild
type mice. This was determined using polymerase
chain reaction amplification of cDNA prepared from
a mixture of stromal and haemopoietic cells (Le &
O’Neill, unpublished data).
LTC producing DC can be established from both
BM and spleen cell populations of GM-CSF-/- mice.
While stroma takes longer to form in GM-CSF-/-LTC
than in WT LTC, GM-CSF-/- spleen and BM LTC
actively produce cells resembling DC after 16 weeks.
Mutational loss of GM-CSF appears to impact on the
nature and growth potential of the stromal cell layer.
However, the effect is not critical and an adequate
stromal cell layer does develop within 4 weeks of
LTC establishment.
DC produced in established GM-CSF-/- spleen LTC
resemble DC produced in WT LTC in terms of cell
morphology, phenotype and antigen presenting capac-
ity. The proportion of large DC at 16 weeks is slightly
lower in GM-CSF-/- spleen LTC than in WT cultures.
However, since both GM-CSF
-/- and WT LTC pro-
duce lower numbers of DC than the well developed
LTC-X1 culture derived from B10.A(2R) mice, this
difference could reflect strain differences in DC pro-
duction. Similar numbers of large DC are produced in
both GM-CSF-/- and WT LTC. Consistent with previ-
ous studies, spleen LTC are easier to establish than
BM LTC and they produce higher numbers of
non-adherent DC (Ni & O’Neill, 1997).
The importance of stromal cells and
stroma-derived factors in DC development from hae-
mopoietic progenitors maintained in LTC has been
demonstrated previously (Ni & O’Neill, 1998). A
combination of conditioned medium from LTC and
stromal cells very effectively supports the formation
of mature DC colonies in agar colony assays (Wilson
et al., 2000 a). However, the essential growth factors
produced by stromal cells have not yet been charac-
terised. Conditioned medium from LTC alone will not
support survival of cells indefinitely. With the addi-
tion of stromal cells, regeneration of the DC popula-
tion is easily achieved (Ni & O’Neill, 1998; Wilson et
al., 2000 a). Furthermore, non-adherent cells removed142 KEPING NI and HELEN C. O’NEILL
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FIGURE 6 The effect ofGM-CSF on development ofDC in GM-CSF- -spleen LTC. Antigen expression and cell size distribution were mon-
itored by FACS analysis on days 0, 3, 6 and 12 after addition of 300 U/ml of GM-CSF to the 16 week old 8FZ8.1. LTC. The production of
large DC was monitored by Forward Scatter versus Side Scatter (FSC/SSC) analysis. The size of the large cell subset was identified by a gate
imposed on the control LTC-X1 culture. Expression of MHCII, CD86 and CD lc was measured by antibody staining and FACS analysis on
gated small and large LTC cells collected at different times after addition ofGM-CSF to the culture. Again staining ofLTC-X1 was used as a
controlGM-CSF-INDEPENDENT DENDRITIC CELL DEVELOPMENT 143
from LTC and supported in medium supplemented
with GM-CSF or GM-CSF in combination with inter-
leukin(IL)-4, survive for only 1-2 weeks in the
absence of stromal cells (data not shown). This has
been demonstrated on many occasions for LTC
derived from several different strains of mice. During
culture wit GM-CSF and IL-4, non-adherent cells
collected from LTC adopt a more "dendritic-like"
appearance with predominant membrane extensions.
There is, however, no expansion of precursor cells
and no new production of DC. Small cells disappear,
cultures deteriorate after 1-2 weeks, and large DC die
off (Ni & O’Neill, unpublished observations).
GM-CSF and GM-CSF in combination with IL-4 are
also ineffective in producing DC colonies from
LTC-derived non-adherent cells in agar colony assays
(Wilson et al., 2000 a). This again confirms an impor-
tant role for stroma and stroma-produced soluble fac-
tors but not GM-CSF or IL-4 in the production ofDC
from progenitors.
GM-CSF can also substitute for stromal cells from
GM-CSF-/- LTC in supporting the proliferation of a
small number ofDC colonies. This result is consistent
with the presence ,of haemopoietic progenitors in
LTC. Addition of GM-CSF to progenitors derived
from GM-CSF
-/- LTC induces differentiation/prolifer-
ation of colonies of DC with short membrane exten-
sions. GM-CSF is not, however, a critical factor in the
early stages of DC differentiation from progenitors
and a small number of progenitors are present in LTC
which are GM-CSF responsive. These may represent
cells of a separate lineage or cells at a particular stage
of development.
The data presented here also demonstrate a role for
GM-CSF in maintenance or survival of mature DC in
vitro. This was evident by an increase in the propor-
tion of large cells present in GM-CSF-/- LTC supple-
mented with GM-CSF, and in agar colony assays
where addition of GM-CSF maintained the survival
of individual mature DC. The exact role of GM-CSF
in the maintenance ofDC survival is not yet clear but
is under investigation. One possibility is that
GM-CSF is anti-apoptotic and may act to increase the
lifespan of DC as it does with eosinophils (Simon et
al., 1997). Alternatively, it may influence the matura-
fion or activation ofDC at late stages during develop-
ment. Cells from GM-CSF-/- mice may compensate
for absence of a functional GM-CSF gene by utilising
other stroma-derived factors to support DC survival.
This argument is supported by evidence that addition
of GM-CSF to LTC derived from GM-CSF-/- mice
leads to an increase in the proportion of large DC
present in LTC with no major changes in cell pheno-
type (Fig. 6). GM-CSF may initiate an additional
pathway to support DC survival or maturation from
precursors.
Another consideration is whether LTC-DC are
more closely related to the apparent myeloid or lym-
phoid DC lineages (Shortman & Caux, 1997). Since
LTC-DC develop from progenitors which grow inde-
pendently of GM-CSE they could be closely aligned
with lymphoid DC. However, absence of CD8ot
expression and low expression of Dec-205 would
suggest that LTC-DC are more likely myeloid DC.
Cells described here originate from BM and spleen
which could contain a mixture of progenitors specific
for DC of several different lineages. In the absence of
lineage-specific markers, it is difficult to relate the
phenotypes of DC cultured in vitro to the phenotype
of cell subsets present in different tissue sites in vivo
and which may have different lineage origins (Salo-
monet al., 1998; Leenen et al., 1998). An alternative
explanation is that LTC-DC are predominantly mye-
loid DC, but that myeloidDC have no critical require-
ment for GM-CSF during development. Addition of
GM-CSF to cells in culture may, however, increase
DC survival. Further analysis ofDC subsets and their
development both in vivo and within LTC will require
the development of antibodies uniquely specific for
cells of the different DC lineages.
METHODS AND MATERIALS
Animals
Mice were bred under specific pathogen-free condi-
tions in the John Curtin School of Medical Research,
Canberra, Australia and used when 6 to 10 weeks of144 KEPING NI and HELEN C. ONEILL
age. GM-CSF-/- mice and GM-CSF+/+ littermate con-
trols [(129 C57BL/6J) F hybrid] were purchased
from the Ludwig Institute for Cancer Research, Mel-
bourne, and used at 10 weeks of age.
Production of dendritic cells in LTC
LTC were established from spleen and bone marrow
(BM) as previously described (Ni & O’Neill, 1997;
1998; 1999). Single cell suspensions were made by
pressing spleen or BM through a fine wire mesh.
Cells were cultured at 37C in plastic tissue culture
flasks (Nunclon, Roskilde, Denmark) at a concentra-
tion of 2.5 106 cells/ml in an atmosphere of5% CO2
in air. Dulbecco’s modified Eagle’s medium (Gibco,
Gaitherburg, MD) was used for cell culture following
supplementation with 10% fetal calf serum (FCS), 5
10-SM 2-mercaptoethanol, 10 mM Hepes, 100 U/ml
penicillin, 100 tg/ml streptomycin, 4g/L glucose,
6 mg/L folic acid, 36 mg/L L-asparagine, 116 mg/L
L-arginine HC1 (sDMEM).
Cultures were initially left undisturbed for 10-14
days after establishment. Medium change involved
replacement of 75% volume every 5 days or when
cultures became acidic. A stromal cell layer of fibrob-
lasts and endothelial cells formed initially. By 4
weeks, lymphoid and myeloid cells disappeared from
the culture and foci of haemopoietic cells began to
appear on stroma. By 6-8 weeks these began to shed
non-adherent cells into the supernatent which were
collected for experimentation. Data has been obtained
here from multiple cultures from many individual
mice and specific analysis has been performed on two
different spleen LTC, 8GS 1.4 and 8FZ8.1.
The LTC-X1/3 spleen cultures were established
from B 10.A(2R) mice (Ni & O’Neill, 1997). It has
been maintained in continuous culture for-6 years by
passage of cells and stroma every 2-3 months. DC
collected from LTC-X1 were used as controls in all
experiments. GM-CSF was added to some cultures at
300 U/ml. This was purchased as recombinant mouse
protein from Genzyme (Cambridge, MA). Secondary
cultures were established by seeding BM cells on to
LTC-X1 stroma which had been stripped of
non-adherent cells and irradiated (2Gy; (-source)
Antibodies and fluorochromes
Antibodies used included FITC-conjugated
anti-mouse I-Ab (clone AF6-120.1); biotinylated
anti-mouse CDllc (clone HL1), biotinylated
anti-mouse CD86 (clone GL1), and purified
anti-mouse CD32/CD64 (clone 2.4G2) (all from
Pharmingen, San Diego, CA). Some antibodies were
prepared as hybridoma supernatant. These included
Ml/70 (CDllb), AT83 (Thy-l.2), RA3-6B2 (B220),
RB6-8C5 (Gr- 1), F4/80 (macrophages/DC),
NLDC-145(Dec-205), and 33D1 (spleen DC). Second
stage reagents included goat anti-rat IgG F(ab’)2
(Silenus, Hawthorn, Victoria, Australia) and Strepta-
vidin-phycoerytherin (PE) (Pharmingen, San Diego,
CA).
Single colour immunostaining
Antigen expression was assessed in either a direct
assay using fluorochrome conjugated antibody or an
indirect assay using a fluorochrome-conjugated sec-
ond stage reagent. The staining procedure has been
described previously (O’Neill & Ni, 1993). Briefly,
non-adherent cells (105 106) were collected from
LTC, and washed twice with sDMEM/0.1% NaN3bY
centrifugation at 700 g for 5 min. Specific antibody
was absorbed to cells in a 50 tl volume in the wells of
a microtitre plate. After incubation for 30 min on ice,
cells were washed thrice with medium by centrifuga-
tion (350 g for 2 min). The same procedure was
repeated for absorption of a labelled second stage rea-
gent. Fluorescence was measured by log analysis
using a FACSort (Becton Dickinson, San Jose, CA).
For indirect staining, an isotype control antibody was
used to indicate nonspecific staining levels and to set
gates for FACS analysis. Incubation for 15 min at 4
C with the 2.4G2 antibody was used to block Fc
receptor binding of antibody (10 tl of 0.5 mg/ml
2.4G2).
For two colour staining, cells were incubated with
2.4G2 for 15 min at 4C to block Fc receptor binding
and then both FITC-conjugated and biotin-conjugated
specific antibodies were added and cells incubated for
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FCS/sDMEM/0.1% NaN3 and once with PBS/0.1%
NaN3. Cells were then incubated with a fluoro-
chrome-labelled second stage reagent for 30 min at
4C to visualise antibody binding. Cells were washed
thrice with PBS/0.1% NaN3 prior to FACS analysis.
Fluorescence was measured with a FACSort (Becton
Dickinson, San Jose, CA), using an excitation wave-
length of 448 nm. Cell populations of interest were
gated and analysed using CellQuestTM software (Bec-
ton Dickinson, San Jose, CA). Isotype control anti-
bodies were used to delineate positive staining above
background.
Mixed lymphocyte reaction (MLR)
Assays were carried out as described previously
(O’Neill et al., 1999a). Non-adherent cells were col-
lected from LTC, washed twice with sDMEM and
then irradiated (20 Greys, y-irradiation, 6Co source)
before use as antigen presenting cells (APC). They
were added in graded numbers to 105 spleen mononu-
clear cells as responders in a final volume of 200 tl in
96 well U-bottom microtitre plates. Responder spleen
mononuclear cells were prepared by centrifugation
through an Isopaque-Ficoll gradient (10 min, 25,000
rpm). Proliferation was measured by uptake of
3H-Thymidine (3HT) over the final 6 h of a 72 h cul-
ture. Triplicate culture wells were labelled with 1tCi
of 3HT label per well.
In vitro agar colony assay
The method for colony assays has been previously
described (Wilson et al., 2000 a). Non-adherent cells
were collected from spleen LTC derived from
GM-CSF-/mice, washed with sDMEM and resus-
pended into sDMEM at 37C. Double-strength cul-
ture medium (1 ml of 2X sDMEM) at 37C was
mixed with Seaplaque agarose (1.0 ml of 1.6%w/v)
(FMC Bioproducts, Rockland, ME) at 45C and 2 ml
of growth medium containing added factors at 37C
before the addition of 100 ktl of cells at 2x106
cells/ml. One ml of the cell suspension was pipetted
into replicate 35 mm gridded petri dishes (Nunclon,
Roskilde, Denmark). After mixing to distribute cells,
cultures were allowed to gel by cooling for 4-5 mins
at 4C. Cultures were then incubated at 37C in 5%
CO2in air. Supplements to growth medium included
(1.) GM-CSF, (2.) conditioned medium (CSN) col-
lected from LTC or (3.) stromal cells prepared from
LTC 8FZ8.1, derived from the spleen of GM-CSF
-/-
mouse. CSN was collected from LTC-X1 or from
spleen LTC established from GM-CSF
-/- mice at 48
and 72 h after medium change.
After 7,10 and 14 days of incubation, colony devel-
opment was monitored microscopically. At 14 days,
agar cultures were fixed with acetone for in situ
Wright-Giemsa staining. DC can be identified by their
unique staining pattern with Wright-Giemsa. Discrete
.aggregates of 5 or more DC were scored as colonies,
in line with other published reports (Reid et al., 1992).
DC cells were identified by their membrane exten-
sions and characteristic staining of dark blue nucleus
and faint pink cytoplasm. DC staining is very distinc-
tive in comparison with other cell types including
monocytes/macrophages (unpublished data). Type I
DC colonies were identified by short membrane
extensions on cells and Type II DC colonies by long
membrane extensions.
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